Učitavanje...
Tumor responsiveness to statins requires overexpression of the ARF6 pathway
The mevalonate pathway results in the prenylation of small GTPases, which are pivotal for oncogenesis and cancer malignancies. However, inhibitors of this pathway, such as statins, have not necessarily produced favorable results in clinical trials. We recently identified properties of statin respond...
Spremljeno u:
| Izdano u: | Mol Cell Oncol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972113/ https://ncbi.nlm.nih.gov/pubmed/27652329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2016.1185564 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|